Index | MSCI Europe |
Investment focus | Equity, Europe |
Fund size | GBP 6,247 m |
Total expense ratio | 0.12% p.a. |
Replication | Physical (Optimized sampling) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 10.05% |
Inception/ Listing Date | 25 September 2009 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | other |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 30 June |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
Novo Nordisk A/S | 4.31% |
ASML Holding NV | 3.78% |
Nestlé SA | 2.49% |
AstraZeneca PLC | 2.21% |
Shell Plc | 2.10% |
SAP SE | 1.94% |
Novartis AG | 1.93% |
LVMH Moët Hennessy Louis Vuitton SE | 1.93% |
Roche Holding AG | 1.78% |
HSBC Holdings Plc | 1.50% |
YTD | +5.76% |
1 month | -2.23% |
3 months | -3.32% |
6 months | +6.94% |
1 year | +11.41% |
3 years | +17.59% |
5 years | +41.96% |
Since inception (MAX) | +189.20% |
2023 | +13.80% |
2022 | -4.27% |
2021 | +17.34% |
2020 | +2.32% |
Volatility 1 year | 10.05% |
Volatility 3 years | 14.57% |
Volatility 5 years | 17.15% |
Return per risk 1 year | 1.13 |
Return per risk 3 years | 0.38 |
Return per risk 5 years | 0.42 |
Maximum drawdown 1 year | -6.48% |
Maximum drawdown 3 years | -15.96% |
Maximum drawdown 5 years | -28.65% |
Maximum drawdown since inception | -28.65% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
London Stock Exchange | GBX | SMEA | - - | - - | - |
gettex | EUR | EUNK | - - | - - | - |
Stuttgart Stock Exchange | EUR | EUNK | - - | - - | - |
Bolsa Mexicana de Valores | MXN | - | IMEAN MM | EUNKN.MX | |
Borsa Italiana | EUR | SMEA | SMEA IM INAVIMEE | SMEA.MI IMACEUR.DE | |
Euronext Amsterdam | EUR | IMAE | IMAE NA INAVIMEE | IMAE.AS IMACEUR.DE | |
London Stock Exchange | GBP | - | SMEA LN INAVIMEG | SMEA.L IMACGBP.DE | |
London Stock Exchange | EUR | IMEA | IMEA LN INAVIMEE | IMACEUR.DE | |
SIX Swiss Exchange | CHF | IMEA | IMEA SE INAVIMEC | IMEA.S IMACCHF.DE | |
XETRA | EUR | EUNK | EUNK GY INAVIMEE | EUNK.DE IMACEUR.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Core MSCI Europe UCITS ETF EUR (Dist) | 7,550 | 0.12% p.a. | Distributing | Sampling |
Xtrackers MSCI Europe UCITS ETF 1C | 4,146 | 0.12% p.a. | Accumulating | Full replication |
Amundi Index ETF MSCI Europe UCITS ETF DR (C) | 1,979 | 0.12% p.a. | Accumulating | Full replication |
Amundi MSCI Europe II UCITS ETF Acc | 723 | 0.25% p.a. | Accumulating | Full replication |
Amundi Index MSCI Europe UCITS ETF DR EUR (D) | 321 | 0.12% p.a. | Distributing | Full replication |